Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study

NCT03759678 is registered in ClinicalTrials.gov with IntraBio Inc as lead sponsor.

NCT NCT03759678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03759678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study
Lead sponsor
IntraBio Inc
Phase
Phase 2
Overall status
Terminated
Start date
January 8, 2020
Completion date
October 27, 2025
Enrollment
17 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia telangiectasia